Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

5.73USD
15 Dec 2017
Change (% chg)

$0.19 (+3.43%)
Prev Close
$5.54
Open
$5.64
Day's High
$5.73
Day's Low
$5.56
Volume
742,936
Avg. Vol
263,580
52-wk High
$11.71
52-wk Low
$4.61

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.23 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.25 1.25 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 3.20 3.60 3.00 14.80
Quarter Ending Mar-18 1 4.70 4.70 4.70 --
Year Ending Dec-17 4 11.00 11.40 10.80 43.66
Year Ending Dec-18 4 41.52 48.90 32.10 104.55
Earnings (per share)
Quarter Ending Dec-17 4 -0.23 -0.21 -0.26 -0.04
Quarter Ending Mar-18 1 -0.19 -0.19 -0.19 --
Year Ending Dec-17 4 -0.92 -0.90 -0.95 -0.37
Year Ending Dec-18 4 -0.62 -0.47 -0.73 0.17

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 3.52 2.70 0.82 23.38
Quarter Ending Jun-17 3.67 2.77 0.91 24.76
Quarter Ending Mar-17 4.49 2.35 2.15 47.75
Quarter Ending Dec-16 4.44 4.65 0.21 4.75
Quarter Ending Sep-16 52.90 53.85 0.95 1.80

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3.20 3.20 3.20 6.36 14.80
Quarter Ending Mar-18 4.70 4.70 4.70 10.00 --
Year Ending Dec-17 11.00 11.00 11.00 15.02 43.66
Year Ending Dec-18 41.52 41.52 41.52 60.80 104.55

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings